Prelude Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.15

-0.32 (-7.16%)

As of May 16, 2:11 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +127.0% upside

Low Target $6.99

Average Target $9.42

High Target $10.52

Current Price $4.15

Current
$4.15

Target
$9.42

$6.99 $9.42 avg $10.52

Scenario Analysis

Bear Case

$6.99

68.4%

Low target

Base Case

$9.42

+127.0%

Avg target

Bull Case

$10.52

+153.5%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$5.54

-25.1% from high

52-Week Low

$0.75

+453.3% from low

Target vs 52W High

$9.42

+70.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%